CDKN2B and neoplasm: Dasgupta et al. found that CDKN2B-AS1 expression as an oncogenic lncRNA increased from lower grade and stage to higher grade and stage in renal cell carcinoma based on the TCGA-KIRC (normal  =  72, tumor  =  518), TCGA-KICH (normal  =  25, tumor  =  66), and TCGA-KIRP (normal  =  30, tumor  =  197; p < 0.05) databases.